Klin Onkol 2016; 29(Suppl 1): 62-70. DOI: 10.14735/amko2016S62.
Summary
There is a broad spectrum of hereditary cancer predisposition syndromes aff ecting pediatric population. Early genetic testing establishing the diagnosis may assist in patient dispensarisation and management. Secondary prevention and prompt diagnosis of cancer improves the prognosis and overall survival. A centralised dispensarisation of pediatric patients with hereditary cancer predisposition syndromes on pediatric oncology department off ers complex multidisciplinary care to the patient and his family.
